About 686,000 results
Open links in new tab
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
FDA approves ribociclib with an aromatase inhibitor and ribociclib …
FDA Approves Adjuvant Ribociclib in HR+/HER2– Breast Cancer
Ribociclib Combo Approved in HR+/HER2- Stage II-III Early Breast Cancer
Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– Breast Cancer
NATALEE Trial Long-Term Results on Ribociclib Combination …
Ribociclib Improves Survival in Advanced Breast Cancer
Ribociclib plus Endocrine Therapy in Early Breast Cancer
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as …